Neovasc Inc, a specialty medical device company, develops, manufactures, and markets cardiovascular devices worldwide. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company also provides Peripatch tissue products. The company was formerly known as Medical Ventures Corp.
Read More…
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Phone604-270-4344
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$1.75 million
Profitability
Miscellaneous
Employees98
Next Earnings Date11/13/2019 (Estimated)
OptionableNot Optionable
Neovasc (NASDAQ:NVCN) Frequently Asked Questions
What is Neovasc's stock symbol?
Neovasc trades on the NASDAQ under the ticker symbol "NVCN."
When did Neovasc's stock split? How did Neovasc's stock split work?
Neovasc's stock reverse split on the morning of Friday, September 21st 2018. The 1-100 reverse split was announced on Tuesday, September 11th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, September 20th 2018. An investor that had 100 shares of Neovasc stock prior to the reverse split would have 1 shares after the split.
How were Neovasc's earnings last quarter?
Neovasc Inc (NASDAQ:NVCN) released its quarterly earnings results on Wednesday, August, 7th. The medical equipment provider reported ($1.17) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.70) by $0.53. The medical equipment provider earned $0.44 million during the quarter, compared to the consensus estimate of $0.60 million. View Neovasc's Earnings History.
When is Neovasc's next earnings date?
Has Neovasc been receiving favorable news coverage?
Media headlines about NVCN stock have been trending somewhat positive recently, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Neovasc earned a media sentiment score of 0.9 on InfoTrie's scale. They also gave media stories about the medical equipment provider a news buzz of 1.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for Neovasc.
Who are some of Neovasc's key competitors?
Some companies that are related to Neovasc include BRAINSWAY LTD/S (BWAY), Sensus Healthcare (SRTS), Endologix (ELGX), Liquidia Technologies (LQDA), Motus GI (MOTS), Apollo Endosurgery (APEN), STRATA Skin Sciences (SSKN), Spectral Medical (EDTXF), Pro-Dex (PDEX), Nephros (NEPH), AIT Therapeutics (AITB), BeyondAirInc . (XAIR), Nephros (NEPHD), Arch Therapeutics (ARTH) and Titan Medical (TMDI).
What other stocks do shareholders of Neovasc own?
Who are Neovasc's key executives?
Neovasc's management team includes the folowing people:
- Mr. Fredericus A. Colen, Pres & CEO (Age 66)
- Mr. Christopher Clark B.A., C.A., BA (Honours), PgD, CA, CFO & Corp. Sec. (Age 47)
Who are Neovasc's major shareholders?
Neovasc's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Magnetar Financial LLC (64.30%), Citadel Advisors LLC (0.98%) and Bank of Montreal Can (0.69%).
Which institutional investors are buying Neovasc stock?
NVCN stock was acquired by a variety of institutional investors in the last quarter, including Magnetar Financial LLC, Citadel Advisors LLC and Bank of Montreal Can.
How do I buy shares of Neovasc?
Shares of NVCN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Neovasc's stock price today?
One share of NVCN stock can currently be purchased for approximately $4.04.
How big of a company is Neovasc?
Neovasc has a market capitalization of $30.22 million and generates $1.75 million in revenue each year. The medical equipment provider earns $-108,040,000.00 in net income (profit) each year or ($27.30) on an earnings per share basis. Neovasc employs 98 workers across the globe.View Additional Information About Neovasc.
What is Neovasc's official website?
How can I contact Neovasc?
Neovasc's mailing address is Suite 5138 - 13562 Maycrest Way, Richmond A1, V6V 2J7. The medical equipment provider can be reached via phone at 604-270-4344 or via email at [email protected]
MarketBeat Community Rating for Neovasc (NASDAQ NVCN)
MarketBeat's community ratings are surveys of what our community members think about Neovasc and other stocks. Vote "Outperform" if you believe NVCN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NVCN will underperform the S&P 500 over the long term. You may vote once every thirty days.
